12:00 AM
Aug 11, 2014
 |  BC Week In Review  |  Financial News  |  Amended Offerings

Celladon amends follow-on

Celladon Corp. (NASDAQ:CLDN), San Diego, Calif.
Business: Cardiovascular, Endocrine/Metabolic, Neurology
Date announced: 2014-08-07
Type: Follow-on

Read the full 59 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >